Takahama Hiroko, Asanuma Hiroshi, Tsukamoto Osamu, Ito Shin, Kitakaze Masafumi
Department of Clinical Research and Development, National Cerebral and Cardiovascular Center, 5-7-1 Fujishirodai, Suita, Osaka, Japan.
Department of Cell Biology, National Cerebral and Cardiovascular Center, 5-7-1 Fujishirodai, Suita, Osaka, Japan.
Int J Cardiol Heart Vasc. 2019 Jul 10;24:100396. doi: 10.1016/j.ijcha.2019.100396. eCollection 2019 Sep.
Endogenous adenosine levels increase under stress in various organs. Exogenously administered adenosine is a well-known pulmonary vasodilator. However, the physiology and therapeutic potential of endogenous adenosine during alteration in pulmonary hemodynamics such as pulmonary embolism is not elucidated. We hypothesized that the adenosine level increases following an acute elevation of pulmonary resistance, resulting in pulmonary vasodilation.
We induced acute pulmonary embolization by injecting plastic beads in anesthetized dogs. Plasma adenosine levels, defined as the product of plasma adenosine concentration and simultaneous cardiac output, were assessed from blood samples from the superior vena cava, main pulmonary artery (MPA), and ascending aorta 1 and 10 min following injection. Hemodynamics were assessed with ( = 3) and without ( = 8) administration of the adenosine receptor blocker, 8-(-sulfophenyl)theophylline (8SPT).
Mean pulmonary arterial pressure (PAP) increased from 11 ± 1 mmHg, peaking at 28 ± 4 mmHg at 52 ± 13 s after injection. During this period, total pulmonary resistance (TPR) elevated from 11 ± 1 to 33 ± 6 Wood unit. Plasma adenosine levels increased in the MPA from 14.5 ± 2 to 38.8 ± 7 nmol/min 1 min after injection. TPR showed greater elevation under 8SPT treatment, to 96 ± 12 Wood unit at PAP peak.
Endogenously released adenosine after acute pulmonary embolization is one of the initial pulmonary vasodilators. The immediate surge in plasma adenosine levels in the MPA could lead to a hypothesis that adenosine is released by the right heart in response to pressure overload.
在各种器官遭受应激时,内源性腺苷水平会升高。外源性给予的腺苷是一种众所周知的肺血管扩张剂。然而,在诸如肺栓塞等肺血流动力学改变过程中内源性腺苷的生理学及治疗潜力尚未阐明。我们推测,肺阻力急性升高后腺苷水平会升高,从而导致肺血管扩张。
我们通过向麻醉的犬体内注射塑料珠诱导急性肺栓塞。在注射后1分钟和10分钟,从上腔静脉、主肺动脉(MPA)和升主动脉采集血样,评估血浆腺苷水平,血浆腺苷水平定义为血浆腺苷浓度与同时的心输出量的乘积。在给予(n = 3)和不给予(n = 8)腺苷受体阻滞剂8 -(-磺基苯基)茶碱(8SPT)的情况下评估血流动力学。
平均肺动脉压(PAP)从11±1 mmHg升高,在注射后52±13秒时达到峰值28±4 mmHg。在此期间,总肺阻力(TPR)从11±1升高至33±6伍德单位。注射后1分钟,MPA中的血浆腺苷水平从14.5±2升高至38.8±7 nmol/min。在8SPT治疗下,TPR升高幅度更大,在PAP峰值时达到96±12伍德单位。
急性肺栓塞后内源性释放的腺苷是最初的肺血管扩张剂之一。MPA中血浆腺苷水平的立即激增可能导致一种假设,即腺苷是右心对压力过载作出反应而释放的。